Phase 2 Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with either Type 1 or Type 2 diabetes
- People whose HbA1c (a blood test that measures average blood sugar levels over about 3 months) is at or below 9%
- People who have had pain in both legs or feet caused by diabetic nerve damage (a condition where nerves are affected in a symmetrical pattern, starting from the feet), lasting for at least 1 year
Who may not be able to join:
- People whose nerve pain is caused by something other than diabetes
- People who have a history of irregular heart rhythms that have required medication or other treatment to manage
- People who have had a major heart or blood vessel event, such as a heart attack or stroke, within the past 12 months
- Other criteria set out in the trial protocol may also apply (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 617-341-6777
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change From Baseline in the Weekly Average of Daily Pain Intensity on the Numeric Pain Rating Scale (NPRS) at Week 12
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.